2025 HCPCS Code G9078
Oncology; disease status; prostate cancer, limited to adenocarcinoma as predominant cell type; t2 or t3a gleason 8-10 or psa > 20 at diagnosis with no evidence of disease progression, recurrence, or metastases (for use in a medicare-approved demonstration project)
TAGS: prostate adenocarcinoma disease gleason demonstration limited evidence predominant diagnosis metastases| Short Description | Onc dx prostate t2no progres |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | January 01, 2006 |
| HCPCS Action Effective Date | January 01, 2007 |
| HCPCS Pricing Indicator Code | 00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.) |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- G8960 - Clin tx mdd not comm
- G8961 - Csit lowrisk surg pts preop
- G8962 - Csit on pt any reas 30 days
- G8963 - Csi per asx pt w/pci 2 yrs
- G8964 - Csi any other than pci 2 yr
- G8965 - Csit perf on low chd rsk
- G8966 - Csit perf sx or high chd rsk
- G8967 - Warf or other fda drug presc
- G8968 - Doc med not presb
- G8969 - Doc pt rsn no presc warf/fda
- G8970 - No rsk fac or 1 mod risk te
- G8971 - Warfrn or othr antcog no rx
- G8972 - 1>=risk or>= mod risk for te
- G8973 - Mst rcnt hbb < 10g/dl
- G8974 - Hgb not doc rns not gvn
- G8975 - Hgb <10g/dl, med rsn
- G8976 - Hgb >= 10 g/dl
- G8977 - Oncology measures grp
- G8978 - Mobility current status
- G8979 - Mobility goal status